Pfizer (PFE) beats Q2 analyst expectations

Pfizer (NYSE: PFE) reported better-than-expected results for its second quarter.

The pharma giant reported a profit per share of 67 cents on revenue of $12.7 billion, beating the analyst consensus for a profit per share of 57 cents on revenue of $12.08B. Overall, revenue fell 54% year-over-year amid a major decline in Covid19-related sales.

Dr. Albert Bourla, Chairman and Chief Executive Officer, stated: “We look forward to continuing our progress in the second half of 2023, driven by commercial execution, scientific innovation and our never-ending commitment to delivering breakthroughs for patients.”

The company sees full-year EPS at $3.35 on revenue of $68.5B. Analysts were looking for EPS of $3.01 on revenue of $61B.

By Senad Karaahmetovic

You May Also Be Interested In

• Next-Generation DNA Repair Inhibitors Could Capture Billions in Emerging Market
• Micron Technology (MU) Tops Q3 EPS by $4.62, Guidance Beats
• Darden Restaurants (DRI) Tops Q4 EPS by 3c, Misses on Revenue; Offers FY27 Guidance